COMP <GO>
CPRT vs PG // RSI-14 & 200D SMA MOMENTUM
Copart Inc. (DE) (NASDAQ) VS. Procter & Gamble Company (The) (NYSE) • 15-METRIC TALLY: CPRT 8
— PG 7
▲ RSI-14 & 200D SMA MOMENTUM LEADER: CPRT
LAST: $30.13 (+1.96%) • MKT CAP: $27.37B
rsi-technicals
63.5
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
rsi-technicals
62.7
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CPRT VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CPRT | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 51.20% | -10.20 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 15.10% | 25.40% | -10.30 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 12.1x | 16.2x | -4.10 | CPRT | /valuation <GO> |
| Free Cash Flow Yield | 4.50% | 3.77% | +0.73 | CPRT | /fcf-yield <GO> |
| Operating Margin | 22.10% | 24.30% | -2.20 | PG | /operating-margins <GO> |
| Net Profit Margin | 20.30% | 19.00% | +1.30 | CPRT | /net-margins <GO> |
| Revenue Growth (YoY) | -2.20% | 0.30% | -2.50 | PG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.65% | -2.65 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 23.87 | 5.59 | +18.28 | CPRT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | CPRT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.40% | 6.50% | +0.90 | PG | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 63.5 | 62.7 | +0.84 | CPRT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.15 | 0.87 | +0.28 | CPRT | /macro-sensitivity <GO> |
| Forward P/E Multiple | 16.4x | 21.7x | -5.30 | CPRT | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $27.37B | $372.21B | -$344.84B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CPRT REV | PG REV | CPRT GROSS % | PG GROSS % | CPRT FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $84.28B | — | 51.2% | $1.23B | $14.04B |
| FY 2024 | $0 | $84.04B | — | 51.4% | $961.6M | $16.52B |
| FY 2023 | $0 | $82.01B | — | 44.0% | $1.36B | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CPRT // BETA 1.15
PG // BETA 0.87